Optinose As
Patents = 74
Trademarks = 7
Forward Citations = 3,267
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
52 inventors (with patents filed for the assignee):
OptiNose AS is a pharmaceutical company that specializes in innovative nasal drug delivery solutions. We develop and commercialize products that optimize the treatment of medical conditions through the nose. Our patented technology, called Exhalation Delivery System (EDS), enables targeted drug delivery deep into the nasal cavity, providing improved efficacy and patient convenience. At OptiNose, we aim to improve the lives of patients by advancing the science of nasal drug delivery and providing innovative treatment options.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com